Published in Parkinsons Dis on March 15, 2011
Beyond ubiquitination: the atypical functions of Fbxo7 and other F-box proteins. Open Biol (2013) 0.91
Pathogenesis of target organ damage in hypertension: role of mitochondrial oxidative stress. Int J Mol Sci (2014) 0.87
Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system. Surg Neurol Int (2012) 0.86
Oxidative stress mechanisms underlying Parkinson's disease-associated neurodegeneration in C. elegans. Int J Mol Sci (2013) 0.85
Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms. J Neuroinflammation (2015) 0.83
Pale body-like inclusion formation and neurodegeneration following depletion of 26S proteasomes in mouse brain neurones are independent of α-synuclein. PLoS One (2013) 0.81
Cumulative exposure to lead and cognition in persons with Parkinson's disease. Mov Disord (2012) 0.80
Diquat causes caspase-independent cell death in SH-SY5Y cells by production of ROS independently of mitochondria. Arch Toxicol (2015) 0.79
Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson's disease. Protoplasma (2016) 0.78
Mitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson disease. Am J Pathol (2013) 0.77
Activation of Mitochondrial Complex II-Dependent Respiration Is Beneficial for α-Synucleinopathies. Mol Neurobiol (2015) 0.77
Betaine protects against rotenone-induced neurotoxicity in PC12 cells. Cell Mol Neurobiol (2013) 0.77
Systems biology analysis of the proteomic alterations induced by MPP(+), a Parkinson's disease-related mitochondrial toxin. Front Cell Neurosci (2015) 0.76
Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activity. Dis Model Mech (2016) 0.76
In Vitro and in Vivo Neuroprotective Effects of Walnut (Juglandis Semen) in Models of Parkinson's Disease. Int J Mol Sci (2016) 0.75
Alteration of striatal tetrahydrobiopterin in iron-induced unilateral model of Parkinson's disease. Korean J Physiol Pharmacol (2014) 0.75
Colonic Oxidative and Mitochondrial Function in Parkinson's Disease and Idiopathic REM Sleep Behavior Disorder. Parkinsons Dis (2017) 0.75
Neurochemical evidence that the metabolites accumulating in 3-methylcrotonyl-CoA carboxylase deficiency induce oxidative damage in cerebral cortex of young rats. Cell Mol Neurobiol (2012) 0.75
Sequence and organization of the human mitochondrial genome. Nature (1981) 57.39
Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging (2002) 22.40
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature (1998) 21.49
Alpha-synuclein in Lewy bodies. Nature (1997) 20.83
Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science (2004) 15.91
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature (2006) 15.69
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron (2004) 14.35
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol (2010) 12.26
PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol (2010) 11.85
Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci (2000) 10.62
Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science (2002) 9.90
Maternal inheritance of human mitochondrial DNA. Proc Natl Acad Sci U S A (1980) 9.48
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science (1983) 9.41
alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A (1998) 8.41
Mitochondria: dynamic organelles in disease, aging, and development. Cell (2006) 8.30
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet (2000) 7.83
Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J (2003) 7.21
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci U S A (2005) 6.98
Parkinson's disease. Lancet (2009) 6.60
High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet (2006) 6.52
Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med (2000) 6.25
Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem (1991) 5.84
Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci (2007) 5.68
The machines that divide and fuse mitochondria. Annu Rev Biochem (2007) 5.56
Cytochrome C-mediated apoptosis. Annu Rev Biochem (2004) 5.38
Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature (2002) 5.32
Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc Natl Acad Sci U S A (2008) 4.97
Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem (2009) 4.90
Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem (2004) 4.86
The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci U S A (2004) 4.76
Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet (2006) 4.61
The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol (2007) 4.60
The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron (2003) 4.49
The ubiquitin pathway in Parkinson's disease. Nature (1998) 4.48
Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem (1990) 4.03
Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet (2006) 4.01
DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep (2004) 3.84
Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci U S A (2005) 3.83
Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet (2005) 3.76
Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol (2006) 3.72
Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet (2009) 3.59
Complex I is the major site of mitochondrial superoxide production by paraquat. J Biol Chem (2007) 3.31
Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci (2006) 3.20
PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell (2009) 3.17
PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet (2006) 2.97
The internal structure of mitochondria. Trends Biochem Sci (2000) 2.94
Mitochondria: the hub of cellular Ca2+ signaling. Physiology (Bethesda) (2008) 2.93
Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol (2002) 2.92
Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc Natl Acad Sci U S A (2007) 2.77
Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci (1985) 2.70
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res (1979) 2.61
Respiratory complex III is required to maintain complex I in mammalian mitochondria. Mol Cell (2004) 2.61
Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology (1997) 2.61
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol (2009) 2.60
Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol (1988) 2.59
The organization and inheritance of the mitochondrial genome. Nat Rev Genet (2005) 2.57
Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem (2008) 2.53
PINK1 protein in normal human brain and Parkinson's disease. Brain (2006) 2.49
Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila. J Neurosci (2009) 2.47
Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH:ubiquinone oxidoreductase (complex I). J Biol Chem (2004) 2.42
DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci U S A (1996) 2.38
Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology (1998) 2.37
Rhomboid-7 and HtrA2/Omi act in a common pathway with the Parkinson's disease factors Pink1 and Parkin. Dis Model Mech (2008) 2.29
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum Mol Genet (2005) 2.28
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem (1989) 2.26
Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J Biol Chem (2005) 2.26
Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun (1989) 2.23
Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature (2003) 2.22
Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol Cell Biol (2004) 2.15
Mitochondria are a major source of paraquat-induced reactive oxygen species production in the brain. J Biol Chem (2007) 2.13
Experimental models of Parkinson's disease. Nat Rev Neurosci (2001) 2.06
Mitochondrial calcium transport: mechanisms and functions. Cell Calcium (2001) 2.03
The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem (2001) 1.99
Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite. J Biol Chem (2000) 1.97
An out-of-frame cytochrome b gene deletion from a patient with parkinsonism is associated with impaired complex III assembly and an increase in free radical production. Ann Neurol (2000) 1.95
Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia. Cell Death Differ (1998) 1.92
Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am J Pathol (1991) 1.86
Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics. Hum Mol Genet (2010) 1.83
Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system. Neurobiol Dis (2006) 1.83
Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies. J Neurosci (2008) 1.79
Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations. Mov Disord (2004) 1.79
Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann Neurol (1995) 1.79
NADH- and NADPH-dependent formation of superoxide anions by bovine heart submitochondrial particles and NADH-ubiquinone reductase preparation. Biochem J (1979) 1.76
Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J Neurosci (2003) 1.74
Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am J Hum Genet (2001) 1.71
Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration. PLoS One (2009) 1.71
MPTP as a mitochondrial neurotoxic model of Parkinson's disease. J Bioenerg Biomembr (2004) 1.69
Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem (1990) 1.66
Environment, mitochondria, and Parkinson's disease. Neuroscientist (2002) 1.63
Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1. PLoS One (2010) 1.62
Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat. Proc Natl Acad Sci U S A (2008) 1.61
Complex I deficiency in Parkinson's disease frontal cortex. Brain Res (2007) 1.61
The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J Biol Chem (2000) 1.60
A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem (1989) 1.58
Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J Neurochem (1998) 1.56
Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am J Pathol (1992) 1.55
Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am J Pathol (2002) 1.54
Mechanisms of iron-sulfur protein maturation in mitochondria, cytosol and nucleus of eukaryotes. Biochim Biophys Acta (2006) 1.50
Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet (2001) 3.15
Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J Med Genet (2005) 2.56
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics (1997) 2.28
The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. Hum Mol Genet (2005) 1.94
Apolipoprotein E genes in Lewy body and Parkinson's disease. Lancet (1994) 1.77
Pharmacokinetics and clinical toxicity of quinine overdosage: lack of efficacy of techniques intended to enhance elimination. Q J Med (1985) 1.65
The pharmacokinetics of single doses of metoclopramide in renal failure. Eur J Clin Pharmacol (1981) 1.65
Genomic diversity correlates with clinical variation in Ph'-negative chronic myeloid leukaemia. Nature (1986) 1.53
Occupational hazard in hospital staff exposed to 2 per cent glutaraldehyde in an endoscopy unit. J Soc Occup Med (1989) 1.53
Cutting needle biopsy in the diagnosis of clinically suspected non-carcinomatous disease of the lung. Br J Radiol (2000) 1.47
Effects of insecticides. Lancet (2001) 1.41
No evidence of an association between the T16189C mtDNA variant and late onset dementia. J Med Genet (2004) 1.40
Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology (2007) 1.38
The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia. Hum Mol Genet (1998) 1.23
Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies. Neurology (2000) 1.22
Dementia with Lewy bodies. A distinct non-Alzheimer dementia syndrome? Brain Pathol (1998) 1.17
Family study of antipyrine clearance. Br Med J (Clin Res Ed) (1982) 1.15
Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection. Gut (2005) 1.11
Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease. Alzheimer Dis Assoc Disord (1993) 1.11
Telomeric association of chromosomes in B-cell lymphoid leukemia. Hum Genet (1984) 1.10
Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience (1995) 1.08
Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementia. Neuropathol Appl Neurobiol (2006) 1.08
Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use. Neuroscience (1998) 1.02
The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. Int J Geriatr Psychiatry (2001) 1.02
Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients. Biochem J (1992) 0.99
Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease. Neurosci Lett (2000) 0.99
Complex chromosomal translocations in the Philadelphia chromosome leukemias. Serial translocations or a concerted genomic rearrangement? Cancer Genet Cytogenet (1991) 0.98
Determinants of plasma alpha 1-acid glycoprotein (AAG) concentrations in health. Br J Clin Pharmacol (1985) 0.96
SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Neurology (2004) 0.95
Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD. Neurology (2000) 0.92
Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation. J Neurol Neurosurg Psychiatry (2005) 0.91
Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Abeta42 secretion. Hum Mol Genet (1999) 0.90
Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias. Arch Neurol (1999) 0.90
Influence of the amyloid precursor protein locus on dementia in Down syndrome. Neurology (2004) 0.90
Hereditary multi-infarct dementia of the Swedish type is a novel disorder different from NOTCH3 causing CADASIL. Brain (2007) 0.89
Protective effect of apoE epsilon 2 in Alzheimer's disease. Lancet (1994) 0.89
Blood metal ion testing is an effectivescreening tool to identify poorly performing metal-on-metal bearingsurfaces. Bone Joint Res (2013) 0.88
No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease. Hum Mol Genet (1998) 0.88
cDNA cloning of human DEC-205, a putative antigen-uptake receptor on dendritic cells. Immunogenetics (1998) 0.87
Evidence for the repeated primary non-disjunction of chromosome 21 as a result of premature centromere division (PCD). Hum Genet (1986) 0.86
APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment. Neurology (2004) 0.86
Diagnosis of mitochondrial disease: assessment of mitochondrial DNA heteroplasmy in blood. Biochem Biophys Res Commun (1998) 0.86
Human coproantibody secretory immunoglobulin A response to Yersinia species. J Clin Microbiol (1988) 0.86
Adverse health effects after low level exposure to organophosphates. Occup Environ Med (2001) 0.86
Lipoprotein-lipase responses to heparin. Br J Surg (1971) 0.85
Nonrandom cytogenetic changes in New Zealand patients with acute myeloid leukemia. Cancer Genet Cytogenet (1983) 0.85
Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases. J Neurol Sci (1991) 0.85
Lack of association between the dopamine D2 receptor gene allele DRD2*A1 and cigarette smoking in a United Kingdom population. Pharmacogenetics (1998) 0.85
Ambient, biological, and biological effect monitoring of exposure to polycyclic aromatic hydrocarbons (PAHs). Toxicol Lett (1995) 0.84
Clinical management of casualties exposed to lung damaging agents: a critical review. Emerg Med J (2006) 0.84
Aluminium accumulation, beta-amyloid deposition and neurofibrillary changes in the central nervous system. Ciba Found Symp (1992) 0.83
The role of metabolism in determining susceptibility to parathion toxicity in man. Toxicol Lett (1999) 0.83
Trisomy 10 in acute myeloid leukemia: three new cases. Cancer Genet Cytogenet (2000) 0.83
The role of the cholinergic system in the development of the human cerebellum. Brain Res Dev Brain Res (1995) 0.82
Susceptibility of Macaca fascicularis monkeys from Mauritius to different species of Plasmodium. J Parasitol (1992) 0.82
Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation. Brain (2000) 0.82
Nature and role of xenobiotic metabolizing esterases in rat liver, lung, skin and blood. Biochem Pharmacol (1993) 0.82
Integration of human herpesvirus 6 genome in human chromosomes. Lancet (1998) 0.82
Effects of nitrogen oxides on natural killer cells in glass craftsmen and braziers. Occup Environ Med (1996) 0.82
Percutaneous penetration of 2-phenoxyethanol through rat and human skin. Food Chem Toxicol (1998) 0.82
Dopamine-receptor blockade and tardive dyskinesia. Lancet (1979) 0.82
Antibodies to bluetongue and related orbiviruses in sheep and goats in bluetongue virus-endemic areas of northern and central Queensland. Aust Vet J (1995) 0.81
Neuroblastoma and Alzheimer's disease brain cells contain aromatase activity. Steroids (1998) 0.81
Isolation and characterization of the human DTK receptor tyrosine kinase. Growth Factors (1994) 0.81
The effect of sulphur mustard on glutathione levels in rat lung slices and the influence of treatment with arylthiols and cysteine esters. Hum Exp Toxicol (1996) 0.81
Interindividual variations in enzymes controlling organophosphate toxicity in man. Hum Exp Toxicol (1992) 0.81
Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases. Neurology (1998) 0.81
Autoradiographic comparison of cholinergic and other transmitter receptors in the normal human hippocampus. Hippocampus (1993) 0.81
Human xenobiotic metabolizing esterases in liver and blood. Biochem Pharmacol (1993) 0.81
Identification of amplified genes in a patient with acute myeloid leukemia and double minute chromosomes. Cancer Genet Cytogenet (1999) 0.81
Anti-tumour activity of TCNU in a panel of transplantable murine colon tumours. Eur J Cancer Clin Oncol (1988) 0.80
What are the relations between Lewy body disease and AD? J Neural Transm Suppl (1998) 0.80
Nonrandom distribution of interspersed repeat elements in the BCR and ABL1 genes and its relation to breakpoint cluster regions. Genes Chromosomes Cancer (2001) 0.80
The imaging and quantification of aluminium in the human brain using dynamic secondary ion mass spectrometry (SIMS). Biol Cell (1992) 0.80
Complexity of an apparently simple variant Ph translocation in chronic myeloid leukemia. Leuk Res (1987) 0.80
Clonally unrelated BCR-ABL-negative acute myeloblastic leukemia masquerading as blast crisis after busulphan and interferon therapy for BCR-ABL-positive chronic myeloid leukemia. Leukemia (1999) 0.80
Functional genomics and proteomics: application in neurosciences. J Neurol Neurosurg Psychiatry (2004) 0.80
Effects of apolipoprotein E genotype on cortical neuropathology in senile dementia of the Lewy body and Alzheimer's disease. Neurodegeneration (1995) 0.79
Electrophysiological and biochemical effects of single and multiple doses of the organophosphate diazinon in the mouse. Toxicol Appl Pharmacol (2000) 0.79
The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodies. Neuroreport (2000) 0.79
The oncogene ETS1 is distant from the chromosome 11 breakpoint in leukaemic cells with the t(11;19)(q23;p13). Leuk Res (1989) 0.79
Cytogenetic response without changes in peripheral cholinesterase enzymes following exposure to a sheep dip containing diazinon in vivo and in vitro. Mutat Res (2000) 0.78
Cloning, sequence analysis, and chromosomal localization of the novel human integrin alpha11 subunit (ITGA11). Genomics (1999) 0.78
Hereditary vascular dementia linked to notch 3 mutations. CADASIL in British families. Ann N Y Acad Sci (2000) 0.78
Acquired myeloma-associated Type III hyperlipidaemia treated by nonmyeloablative HLA-identical sibling allogeneic stem cell transplant using a donor with essential thrombocythaemia (ET): evidence of engraftment without manifestation of ET in recipient. Bone Marrow Transplant (2005) 0.78
Interferon inhibition of DNA synthesis in Swiss 3T3 cells: dissociation from protein kinase C activation. Biochem Biophys Res Commun (1987) 0.78
Apolipoprotein E genotype and Alzheimer's disease in an elderly Norwegian cohort. Neurodegeneration (1996) 0.78
Impact of hypertension and apolipoprotein E4 on poststroke cognition in subjects >75 years of age. Stroke (2005) 0.78
CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease. Pharmacogenetics (1999) 0.78
The integrin alpha10 subunit: expression pattern, partial gene structure, and chromosomal localization. Cytogenet Cell Genet (1999) 0.78
The percutaneous absorption and skin distribution of lindane in man. I. In vivo studies. Hum Exp Toxicol (1997) 0.78
Brain oestradiol and testosterone levels in Alzheimer's disease. Neurosci Lett (2000) 0.78
Involvement of immunoglobulin heavy- and light-chain (kappa) gene clusters in a human B-cell translocation, t(2;14). Cytogenet Cell Genet (1989) 0.78
Fate of fluazifop butyl in rat and human skin in vitro. Arch Toxicol (1993) 0.78
Butyrylcholinesterase K: an association with dementia with Lewy bodies. Lancet (1998) 0.78
Strychnine poisoning: abnormal eye movements. J Toxicol Clin Toxicol (1982) 0.78
No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer's disease. Neurosci Lett (1997) 0.77
Basophils (Bsp-1+) derive from the leukemic clone in human myeloid leukemias involving the chromosome breakpoint 9q34. Blood (1989) 0.77
The percutaneous absorption and skin distribution of lindane in man. II. In vitro studies. Hum Exp Toxicol (1997) 0.77
Genomic structure, promoter sequence, and revised translation of human homeobox gene HLX1. Genomics (1994) 0.77